Form 8-K - Current report:
SEC Accession No. 0001104659-24-011090
Filing Date
2024-02-06
Accepted
2024-02-06 16:00:49
Documents
18
Period of Report
2023-12-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm245309d1_8k.htm   iXBRL 8-K 33942
2 EXHIBIT 10.1 tm245309d1_ex10-1.htm EX-10.1 69202
3 EXHIBIT 10.2 tm245309d1_ex10-2.htm EX-10.2 80177
7 GRAPHIC tm245309d1_ex10-1img001.jpg GRAPHIC 6158
8 GRAPHIC tm245309d1_ex10-2img001.jpg GRAPHIC 6062
  Complete submission text file 0001104659-24-011090.txt   416304

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bcel-20231231.xsd EX-101.SCH 3009
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcel-20231231_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcel-20231231_pre.xml EX-101.PRE 22355
19 EXTRACTED XBRL INSTANCE DOCUMENT tm245309d1_8k_htm.xml XML 3725
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

EIN.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38935 | Film No.: 24600145
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)